Mast cells and eosinophils: the two key effector cells in allergic inflammation
- 8 May 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Inflammation Research
- Vol. 58 (10), 631-638
- https://doi.org/10.1007/s00011-009-0042-6
Abstract
The allergic inflammatory response is composed of two main phases—the early and the late. The early phase initiates when an allergen activates the tissue resident mast cell, triggering the release of a variety of granule-stored and newly formed mediators. As the inflammatory response progresses, blood borne inflammatory cells—in particular, eosinophils—are recruited into the inflamed tissue. Eosinophil activation and consequent release and production of several pro-inflammatory mediators results in the late phase reaction. A chronic allergic inflammation always features prominent tissue eosinophilia. In this review, we will discuss the possible channels of communication, both soluble and physical, between mast cells and eosinophils that can occur in the late and chronic stages of allergy. Such interactions, that we have termed “the allergic effector unit”, may modulate the severity and/or duration of the allergic inflammatory reaction.Keywords
This publication has 101 references indexed in Scilit:
- Signalling mechanisms regulating the activation of human eosinophils by mast‐cell‐derived chymase: implications for mast cell–eosinophil interaction in allergic inflammationImmunology, 2009
- Eosinophils and mast cells in chronic gastritis: possible implications in carcinogenesisHuman Pathology, 2008
- Modulation of Lung Allergic Inflammation and MalnutritionNeuroimmunomodulation, 2008
- The development of allergic inflammationNature, 2008
- Immune response to allergens in sheep sensitized to house dust miteJournal of Inflammation, 2008
- Mast cell distribution, activation, and phenotype in xanthomaJournal of the American Academy of Dermatology, 2007
- Eotaxin Selectively Binds HeparinPublished by Elsevier BV ,2007
- PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysisMolecular Immunology, 2005
- Intracrine Cysteinyl Leukotriene Receptor–mediated Signaling of Eosinophil Vesicular Transport–mediated Interleukin-4 SecretionThe Journal of Experimental Medicine, 2002
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999